These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 945129)

  • 21. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A non-characteristic response of L1210 cells to lovastatin.
    Engelke KJ; Hacker MP
    Biochem Biophys Res Commun; 1994 Aug; 203(1):400-7. PubMed ID: 8074684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells.
    Liu T; Singh R; Rios Z; Bhushan A; Li M; Sheridan PP; Bearden SE; Lai JCK; Agbenowu S; Cao S; Daniels CK
    Cancer Lett; 2015 Feb; 357(1):231-241. PubMed ID: 25444929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL; Straw JA
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells.
    Scanlon KJ; Kashani-Sabet M; Cashmore AR; Pallai M; Moroson BA; Saketos M
    Cancer Chemother Pharmacol; 1987; 19(1):25-9. PubMed ID: 3815722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cell proliferation and dihydrofolate reductase by liposomes containing methotrexate-dimyristoylphosphatidylethanolamine derivatives and by the glycerophosphorylethanolamine analogs.
    Hashimoto K; Loader JE; Knight MS; Kinsky SC
    Biochim Biophys Acta; 1985 Jun; 816(1):169-78. PubMed ID: 4005236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The metabolism of high-molecular-weight substances in cells and the effect of anticancer drugs].
    Kanamaru R; Kakuta H; Sato T; Ishioka C; Konishi Y; Wakui A; Dei T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):837-44. PubMed ID: 3566294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
    Taylor IW; Tattersall MH
    Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth kinetics of L1210 leukemic cells exposed to different concentration courses of methotrexate in vitro.
    Gimmel S; Maurer HR
    Cancer Chemother Pharmacol; 1994; 34(4):351-5. PubMed ID: 8033302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
    Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.
    Danhauser LL; Heimer R; Cadman E
    Cancer Chemother Pharmacol; 1985; 15(3):214-9. PubMed ID: 3876889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
    Leung BS; Potter AH
    J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
    Van Dolah FM; Ramsdell JS
    J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined antitumoral effects of pretubulysin and methotrexate.
    Kern S; Truebenbach I; Höhn M; Gorges J; Kazmaier U; Zahler S; Vollmar AM; Wagner E
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00460. PubMed ID: 30693087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of interaction between methotrexate and dihydrofolate reductase on DNA synthesis in L1210 cells in vitro.
    Bender RA; Makula DM
    Br J Cancer; 1978 Mar; 37(3):403-10. PubMed ID: 638018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
    Jia ZP; Wang R; Xie JW; Xu LT
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):571-6. PubMed ID: 10678157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
    Sirotnak FM; O'Leary DF
    Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.